Modulation of the AMPK/Sirt1 Axis during Neuronal Infection by Herpes Simplex Virus Type 1

Journal of Alzheimer's Disease

Volumn 42, Issue 1, 2014, Pages 301-312

  Martin, Carolina ^a   Leyton, Luis ^a   Arancibia, Yennyfer ^a   Cuevas, Alexei ^a   Zambrano, Angara ^a   Concha, Margarita I ^a   Otth, Carola ^a,b  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b Universidad Austral de Chile   (Chile)

Author keywords

AMPK; HSV 1; p53; PGC 1 ; Sirt1

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENYLATE KINASE; MITOCHONDRIAL TRANSCRIPTION FACTOR A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN P53; RNA; SIRTUIN 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; SIRT1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOGENESIS; BRAIN CELL CULTURE; BRAIN NERVE CELL; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DEACETYLATION; DOWN REGULATION; EMBRYO; ENZYME ACTIVATION; GENE TARGETING; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; IMMUNOFLUORESCENCE TEST; LATENT PERIOD; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VERO CELL LINE; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL NUCLEUS; DISEASE COURSE; FLUORESCENCE MICROSCOPY; HERPES SIMPLEX; IMMUNOLOGY; METABOLISM; NERVE CELL; SIGNAL TRANSDUCTION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOTTING, WESTERN; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; DISEASE PROGRESSION; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; MICE; MICROSCOPY, FLUORESCENCE; NEURONS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SIRTUIN 1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84929044236     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140237     Document Type: Article

References (57)

1. Saldanha J, Sutton RN, Gannicliffe A, Farragher B, Itzhaki RF (1986) Detection of HSV-1 DNA by in situ hybridisation in human brain after immunosuppression. J Neurol Neurosurg Psychiatry 49, 613-619.
2. Ball M (1982) Limbic predilection in Alzheimer dementia: Is reactivated herpesvirus involved? Can J Neurol Sci 9, 303-306.
3. Jamieson GA, Maitland NJ, Wilcock CK, Yates CM, Itzhaki RF (1992) Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. J Pathol 167, 365-368.
4. Itzhaki R, Dobson C, Shipley S, Wozniak M (2004) The role of viruses and of APOE in dementia. Ann N Y Acad Sci 1019, 15-18.
5. Wozniak MA, Shipley SJ, Combrinck M, Wilcock GK, Itzhaki RF (2005) Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients. J Med Virol 75, 300-306.
6. Bearer EL (2012) HSV, axonal transport and Alzheimer's disease: In vitro and in vivo evidence for causal relationships. Future Virol 7, 885-899.
7. Roizman B, Whitley RJ (2013) An inquiry into the molecular basis of HSV latency and reactivation. Annu Rev Microbiol 67, 355-374.
8. Martin C, Aguila B, Araya P, Vio K, Valdivia S, Zambrano A, Concha MI, Otth C (2014) Inflammatory and neurodegeneration markers during asymptomatic HSV-1 reactivation. J Alzheimers Dis 39, 849-859.
9. Goodkin ML, Ting AT, Blaho JA (2003) NF-kappaB is required for apoptosis prevention during herpes simplex virus type 1 infection. J Virol 77, 7261-7280.
10. Gautier I, Coppey J, DurieuxC(2003) Early apoptosis-related changes triggered by HSV-1 in individual neuronlike cells. Exp Cell Res 289, 174-183.
11. Aubert M, Blaho JA (2001) Modulation of apoptosis during herpes simplex virus infection in human cells. Microbes Infect 3, 859-866.
12. Galvan V, Roizman B (1998) Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-typedependent manner. Proc Natl Acad Sci U S A 95, 3931-3936.
13. Tsalikis J, Croitoru DO, Philpott DJ, Girardin SE (2013) Nutrient sensing and metabolic stress pathways in innate immunity. Cell Microbiol 15, 1632-1641.
14. McArdle J, Moorman NJ, Munger J (2012) HCMV targets the metabolic stress response through activation of AMPK whose activity is important for viral replication. PLoS Pathog 8, e1002502.
15. Moser TS, Schieffer D, Cherry S (2012) AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis. PLoS Pathog 8, e1002661.
16. Di Filippo M, Chiasserini D, Tozzi A, Picconi B, Calabresi P (2010) Mitochondria and the link between neuroinflammation and neurodegeneration. J Alzheimers Dis 20, S369-S379.
17. Ohta A, NishiyamaY(2011) Mitochondria and viruses. Mitochondrion 11, 1-12.
18. Pfister JA, Ma C, Morrison BE, D'Mello SR (2008) Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS One 3, e4090.
19. Araki T, Sasaki Y, Milbrandt J (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305, 1010-1013.
20. Yoshizaki T, Schenk S, Imamura T, Babendure JL, Sonoda N, Bae EJ, Oh DY, Lu M, Milne JC, Westphal C, Bandyopadhyay G, Olefsky JM(2010) SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab 298, E419-E428.
21. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107, 137-148.
22. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA (2004) Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305, 390-392.
23. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, Puigserver P, Sinclair DA, Tsai LH (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26, 3169-3179.
24. Herskovits AZ, Guarente L SIRT1 in neurodevelopment and brain senescence. Neuron 81, 471-483.
25. Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H, NeriC(2005) Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 37, 349-350.
26. Hardie DG (2003) Minireview: The AMP-activated protein kinase cascade: The key sensor of cellular energy status. Endocrinology 144, 5179-5183.
27. Otth C, Torres M, Ramirez A, Fernandez JC, Castro M, Rauch MC, Brito M, Yanez AJ, Rodriguez-Gil JE, Slebe JC, Concha II (2007) Novel identification of peripheral dopaminergic D2 receptor in male germ cells. J Cell Biochem 100, 141-150.
28. Bambrick LL, Krueger BK (1999) Neuronal apoptosis in mouse trisomy 16: Mediation by caspases. J Neurochem 72, 1769-1772.
29. Ejercito PM, Kieff ED, Roizman B (1968) Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol 2, 357-364.
30. Zambrano A, Solis L, Salvadores N, Cortés M, Lerchundi R, Otth C (2008) Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1. J Alzheimers Dis 14, 1-11.
31. Wilcox CL, Johnson EMJr (1987) Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro. J Virol 61, 2311-2315.
32. Wilcox CL, Johnson EM Jr (1988) Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro. J Virol 62, 393-399.
33. Mardones GA, Burgos PV, Brooks DA, Parkinson-Lawrence E, Mattera R, Bonifacino JS (2007) The trans-Golgi network accessory protein p56 promotes long-range movement of GGA/clathrin-containing transport carriers and lysosomal enzyme sorting. Mol Biol Cell 18, 3486-3501.
34. Maccioni RB, Otth C, Concha II, Muñoz JP (2001) The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. Eur J Biochem 268, 1518-1527.
35. Otth C, Concha II, Arendt T, Stieler J, Schliebs R, González-Billault C, Maccioni RB (2002) AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. J Alzheimers Dis 4, 417-430.
36. Mankouri J, HarrisM(2011) Viruses and the fuel sensor: The emerging link between AMPK and virus replication. Rev Med Virol 21, 205-212.
37. Lerchundi R, Neira R, Valdivia S, Vio K, Concha MI, Zambrano A, Otth C (2011) Tau cleavage at D421 by caspase-3 is induced in neurons and astrocytes infected with herpes simplex virus type 1. J Alzheimers Dis 23, 513-520.
38. Muñoz-Fontela C, González D, Marcos-Villar L, Campagna M, Gallego P, González-Santamaría J, Herranz D, Gu W, Serrano M, Aaronson SA, Rivas C (2011) Acetylation is indispensable for p53 antiviral activity. Cell Cycle 10, 3701-3705.
39. Hwang S, Kim KS, Flano E, Wu TT, Tong LM, Park AN, Song MJ, Sanchez DJ, O'Connell RM, Cheng G, Sun R (2009) Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. Cell Host Microbe 5, 166-178.
40. Benetti L, Munger J, Roizman B (2003) The herpes simplex virus 1 US3 protein kinase blocks caspase-dependent double cleavage and activation of the proapoptotic protein BAD. J Virol 77, 6567-6573.
41. Benetti L, Roizman B (2007) In transduced cells, the US3 protein kinase of herpes simplex virus 1 precludes activation and induction of apoptosis by transfected procaspase 3. J Virol 81, 10242-10248.
42. Prasad A, Lu M, Lukac DM, Zeichner SL (2012) An alternative Kaposi's sarcoma-associated herpesvirus replication program triggered by host cell apoptosis. J Virol 86, 4404-4419.
43. Prasad A, Remick J, Zeichner SL (2013) Activation of human herpesvirus replication by apoptosis. J Virol 87, 10641-10650.
44. Tovilovic G, Ristic B, Siljic M, Nikolic V, Kravic-Stevovic T, Dulovic M, Milenkovic M, Knezevic A, Bosnjak M, Bumbasirevic V, Stanojevic M, Trajkovic V (2013) mTORindependent autophagy counteracts apoptosis in herpes simplex virus type 1-infected U251 glioma cells. Microbes Infect 15, 615-624.
45. Kondratowicz AS, Hunt CL, Davey RA, Cherry S, Maury WJ (2013) AMP-activated protein kinase is required for the macropinocytic internalization of ebolavirus. J Virol 87, 746-755.
46. Tanno M, Sakamoto J, Miura T, Shimamoto K, HorioY(2007) Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem 282, 6823-6832.
47. Hisahara S, Chiba S, Matsumoto H, Tanno M, Yagi H, Shimohama S, Sato M, Horio Y (2008) Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation. Proc Natl Acad Sci U S A 105, 15599-15604.
48. Aquilano K, Vigilanza P, Baldelli S, Pagliei B, Rotilio G, Ciriolo MR (2010) Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: Possible direct function in mitochondrial biogenesis. J Biol Chem 285, 21590-21599.
49. Lutz MI, Milenkovic I, Regelsberger G, Kovacs GG (2014) Distinct patterns of sirtuin expression during progression of Alzheimer's disease. Neuromol Med 16, 405-414.
50. Vaseva AV, Moll UM(2009) The mitochondrial p53 pathway. Biochim Biophys Acta 1787, 414-420.
51. Kawaguchi Y, Ito A, Appella E, Yao TP (2006) Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking. J Biol Chem 281, 1394-1400.
52. Green DR, Kroemer G (2009) Cytoplasmic functions of the tumor suppressor p53. Nature 458, 1127-1130.
53. Vingtdeux V, Davies P, Dickson DW, Marambaud P (2011) AMPK is abnormally activated in tangle- and pre-tanglebearing neurons in Alzheimer's disease and other tauopathies. Acta Neuropathol 121, 337-349.
54. Kuramoto N, Wilkins ME, Fairfax BP, Revilla-Sanchez R, Terunuma M, Tamaki K, Iemata M, Warren N, Couve A, Calver A, Horvath Z, Freeman K, Carling D, Huang L, Gonzales C, Cooper E, Smart TG, Pangalos MN, Moss SJ (2007) Phospho-dependent functional modulation of GABA(B) receptors by the metabolic sensor AMP-dependent protein kinase. Neuron 53, 233-247.
55. Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon JE, Janle EM, Lobo J, Ferruzzi MG, Davies P, Marambaud P (2010) AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem 285, 9100-9113.
56. Dasgupta B, Milbrandt J (2007) Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci U S A 104, 7217-7222.
57. Cai Z, Yan LJ, Li K, Quazi SH, Zhao B (2012) Roles of AMP-activated protein kinase in Alzheimer's disease. Neuromolecular Med 14, 1-14.